In summary, these data suggest that anti-PSMA Abs can specifically stimulate NK cells to release more cytotoxic proteins and cytokines and possess more powerful anti-tumor effects against PSMA (+) PCa cells than non-PSMA-targeting Ab. The gene discussed is FOLH1; the disease is neoplasm.